Source disclosure: February 24, 2026
TAKASAGO INTERNATIONAL CORPORATION [4914.T]
TOKYO, Feb 24 (Pulse News Wire) – Takasago International Corporation (4914.T) completed its tender offer for all ordinary shares of Koshu Pharmaceutical Co., Ltd. held by the company, totaling 444,038 shares, through Taiyo Senic Corporation's public offering which ended on February 19, 2026.
The sale was made at a price per share of ¥6,082. As a result, the total proceeds amount to ¥2.700 billion.
Settlement of the transaction will begin on February 27, 2026. This transaction will impact the company’s performance for the fiscal year ending March 2026, with a special gain of ¥2.543 billion expected to be recorded as investment securities sales profit.
Additionally, the company previously disclosed revised forecasts for the full-year consolidated results on February 13, 2026.
AI-translated content. 🟢 Confidence: High See terms • Original filing